Loading clinical trials...
Loading clinical trials...
This study is to evaluate of the accuracy of biomarkers (i.e. circulating endothelial and immune activation markers) that indicate progression to severe disease in patients with suspected COVID-19 in ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Health Network, Toronto
NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more
NCT05101213 · Adenovirus Infection, BK Virus Infection, and more
NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more
NCT06871293 · Long COVID-19 Syndrome, COVID 19, and more
NCT06095297 · Long COVID, Brain Fog, and more
Pontifícia Universidade Católica do Rio Grande do Sul
Porto Alegre
University Health Network
Toronto, Ontario
Cittá della Salute e della Scienza di Torino Hospital-Molinette Site
Turin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions